GUJARAT KIDNEY AND SUPER SPECIALITY
|
|
| BOM : 544666     NSE : GKSL     | |
| LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive] Debt : High |
Updated: |
| ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward Pledged Shares : None or < 25% |
Jun 12,2026 |
|
Price(EOD): ₹ 129.20
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Hospital & Healthcare Services |
| MCap: ₹ 1,018.10 Cr | |
| Industry Peers & Returns | 1W | 1M | 1Y |
| GUJARAT KIDNEY AND SUPER SPECIALITY | -1.6% | -9.2% | NA |
| APOLLO HOSPITALS ENTERPRISE | 1.7% | 6.2% | 22.4% |
| MAX HEALTHCARE INSTITUTE | 0.6% | -1.3% | -13.7% |
| FORTIS HEALTHCARE | 0.3% | 3.5% | 29.5% |
| ASTER DM HEALTHCARE | 6.4% | 10.6% | 40.8% |
| NARAYANA HRUDAYALAYA | -1.4% | 3.9% | 6.2% |
| GLOBAL HEALTH | 1.9% | 3.2% | 1% |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES | -1.7% | 1.3% | 15.8% |
| DR LAL PATHLABS | 3.6% | 1.7% | 11.9% |
FUNDAMENTAL ANALYSIS OF GUJARAT KIDNEY AND SUPER SPECIALITY
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF GUJARAT KIDNEY AND SUPER SPECIALITY
 | Ratio | Consolidated | |
|---|---|---|
|
P/E P/B P/S |
79.94
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 12.74 Cr
[Latest Qtr - Mar2026 - Consolidated Results ] 39.27
P/B Calculated based on Book Value of Rs 25.94 Cr
[Latest Year - Mar2025 - Consolidated Results ] 13.31
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 76.54 Cr
[Latest Qtr - Mar2026 - Consolidated Results ] |
|
| Financial Ratios → | ||
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
7925% 2797% - |
SHARE PRICE MOMENTUM OF GUJARAT KIDNEY AND SUPER SPECIALITY
GUJARAT KIDNEY AND SUPER SPECIALITY vs SENSEX
DEBT OF GUJARAT KIDNEY AND SUPER SPECIALITY
| Year | Debt/Equity ratio | |
|---|---|---|
| Standalone | Consolidated | |
|
2025 2024 2023 Avg_3yrs |
- 1.06 0 0.35 |
0.15 1.12 0 0.42 |
|
[Last Annual Data : Mar2025]
|
||
| Financial Ratios → | ||
PLEDGED PROMOTER SHARES OF GUJARAT KIDNEY AND SUPER SPECIALITY
| Pledged Promoter Shares |
0 % | |
|---|---|---|
| As on : Mar2026 | ||
If less than 25% | Good |
|
| If between 25% and 50% | Neutral | |
| If greater than 50% | Bad | |
| Shareholding Pattern → | ||
QTRLY RESULTS OF GUJARAT KIDNEY AND SUPER SPECIALITY
| Consolidated | Q-o-Q | Y-o-Y |
|---|---|---|
|
Revenue Op Profit Profit Before Tax Profit After Tax |
31.55% -8.67% -6.84% 30.19% |
159.39% 37.1% 30.09% 90.3% |
| QtrlyTrend |
4 | |
| Latest Qtr: Mar2026 | ||
| Quarterly Result Analysis → | ||
GUJARAT KIDNEY AND SUPER SPECIALITY related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE HEALTHCARE | 1% | 2.9% | 10.1% |
| BSE IPO | 0.9% | 4.2% | 12.2% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY IPO INDEX | 0.6% | 4.5% | 7.2% |
You may also like the below Video Courses
FAQ about GUJARAT KIDNEY AND SUPER SPECIALITY
Is GUJARAT KIDNEY AND SUPER SPECIALITY good for long term investment?
As on Jun 12,2026, the Fundamentals of GUJARAT KIDNEY AND SUPER SPECIALITY look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of GUJARAT KIDNEY AND SUPER SPECIALITY . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is GUJARAT KIDNEY AND SUPER SPECIALITY UnderValued or OverValued?
As on Jun 12,2026, GUJARAT KIDNEY AND SUPER SPECIALITY is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of GUJARAT KIDNEY AND SUPER SPECIALITY ?
As on Jun 12,2026, the Intrinsic Value of GUJARAT KIDNEY AND SUPER SPECIALITY is Rs. 3.03 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 1.61
Fair Value [Median EV / Sales Model] : Rs. 4.46
Fair Value [Median Price / Sales Model] : Rs. 0.00
Estimated Median Fair Value of GUJARAT KIDNEY AND SUPER SPECIALITY : Rs. 3.03
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.